FdaApplication
ANDA 208691
Identifiers
- fda_app_no: ANDA208691
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2020-10-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SIROLIMUS | SIROLIMUS | 0.5MG | TABLET;ORAL |
| SIROLIMUS | SIROLIMUS | 2MG | TABLET;ORAL |
| SIROLIMUS | SIROLIMUS | 1MG | TABLET;ORAL |
3 products